Trial
NCT01098240
A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Pfizer
Collaborators
—
Condition
Major Depressive Disorder
Intervention
CP-601,927
Why stopped
See termination reason in detailed description.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-05-03